FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37443611000001104: Seretide 250 Evohaler (CST Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
319391000001118 Seretide 250 Evohaler (CST Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
319401000001115 Seretide 250 Evohaler (CST Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seretide 250 Evohaler (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator CFC free true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Is a Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Is a Seretide Evohaler true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Has dispensed dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - patient training required false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Has dispensed dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Is a Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Is a Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (CST Pharma Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Seretide 250 Evohaler (CST Pharma Ltd) 120 dose Has AMP True Seretide 250 Evohaler (CST Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start